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In cerebral cortex there is a developmental switch
from NR2B- to NR2A-containing NMDA receptors
(NMDARs) driven by activity and sensory experience.
This subunit switch altersNMDARfunction, influences
synaptic plasticity, and its dysregulation is associated
with neurological disorders. However, the mecha-
nisms driving the subunit switch are not known.
Here, we show in hippocampal CA1 pyramidal
neurons that the NR2B to NR2A switch driven acutely
by activity requires activation of NMDARs and
mGluR5, involvesPLC,Ca2+ release from IP3R-depen-
dent stores, and PKC activity. In mGluR5 knockout
mice the developmental NR2B-NR2A switch in CA1
is deficient. Moreover, in visual cortex of mGluR5
knockout mice, the NR2B-NR2A switch evoked
in vivo by visual experience is absent. Thus, we estab-
lish that mGluR5 and NMDARs are required for the
activity-dependentNR2B-NR2Aswitchandplayacrit-
ical role in experience-dependent regulation of
NMDAR subunit composition in vivo.
INTRODUCTION
The NMDA receptor (NMDAR) is a ligand-gated ion channel
permeable to Na+, K+, and Ca2+, and is found at excitatory
synapses throughout the brain. NMDARs are required for many
forms of learning and memory, and are implicated in numerous
neurological disorders (Cull-Candy et al., 2001). Glutamate is
the major excitatory neurotransmitter in the brain; it serves as
the ligand for NMDARs, and receptor activation requires gluta-
mate binding and membrane depolarization. Such coincidence
detection and calcium permeability enables the NMDAR to
play a pivotal role in synaptic function and plasticity (Bliss and
Collingridge, 1993). NMDARs are heterotetramers composed
of two NR1 subunits and two NR2 subunits. Most of the diversity
in the single channel and pharmacological properties of
NMDARs arises from the NR2 subunit composition of the
receptor (Cull-Candy et al., 2001).NMDAR subunit composition varies between different brain
regions and throughout development (Monyer et al., 1994;
Cull-Candy et al., 2001). In cerebral cortex there is a ubiquitous
regulation of NR2 subunit composition during development in
which NR2B is the major NR2 subunit during the first postnatal
week with NR2A expression increasing thereafter (Monyer
et al., 1994; Sans et al., 2000; Sheng et al., 1994). NR2B-contain-
ing NMDARs exhibit slower kinetics than NR2A-containing
receptors (Williams et al., 1993) and are also selectively blocked
by ifenprodil and related compounds (Williams, 1993).
Consistent with the expression changes in NR2 subunits,
NMDAR currents at cortical synapses exhibit faster decay
kinetics and reduced sensitivity to ifenprodil during development
(Carmignoto and Vicini, 1992; Hestrin, 1992; Flint et al., 1997;
Tovar and Westbrook, 1999; Kirson and Yaari, 1996; Williams
et al., 1993), demonstrating that synaptic NMDARs switch from
those predominantly containing NR2B to those containing
NR2A. The switch in NR2 subunit composition is dependent on
neuronal activity and experience. In primary visual cortex the
developmental switch requires visual experience (Carmignoto
and Vicini, 1992) and in dark-reared animals can be rapidly
induced with only 1 hr of exposure to visual experience (Quinlan
et al., 1999; Philpot et al., 2001). Moreover, at synapses on
hippocampal CA1 pyramidal neurons, synaptic activity can drive
NR2A subunits into synapses (Barria and Malinow, 2002), and
LTP induction in the neonate acutely drives the switch of
synaptic NMDARs from NR2B to NR2A containing (Bellone
and Nicoll, 2007). The NR2B to NR2A switch causes important
changes to NMDAR function, altering the amount of calcium
influx through the pore and the types of proteins interacting
with the intracellular domain of the receptor. These features
regulate the type of long-term synaptic plasticity (LTP or LTD)
that NMDAR activation can induce, although the exact relation-
ship between NR2 subunits and the induction of LTP and LTD
remains controversial (Bartlett et al., 2007; Liu et al., 2004;
Morishita et al., 2007; Xu et al., 2009).
Despite the ubiquitous nature and critical roles of the NR2B-
NR2A switch in cortical synapse function and plasticity during
development, the mechanisms for induction of the subunit
switch have not been characterized.We now show that the acute
activity-dependent subunit switch induced by an LTP induction
protocol in hippocampal CA1 pyramidal cells requires activation
of both NMDARs and mGluR5. Furthermore, we find thatNeuron 70, 339–351, April 28, 2011 ª2011 Elsevier Inc. 339
Figure 1. Activity-Dependent Switch from
NR2B- to NR2A-Containing NMDARs at
Hippocampal CA1 Pyramidal Cell Synapses
(A) Summary data of NMDA EPSC peak amplitude
versus time plot for two independent pathways
onto the same cell. In one pathway (test; red), the
induction protocol was applied; ifenprodil (5 mM)
was bath applied at the time indicated.
(B) NMDA EPSCs from example experiments for
the test and control pathways taken at the times
indicated in (A). For this and the other figures,
NMDA EPSCs typically did not exhibit any change
in peak amplitude after the induction protocol and
so are shown superimposed with no amplitude
rescaling.
(C) NMDA EPSCs from an example experiment
showing changes in the ifenprodil sensitivity in the
control and test paths after application of the
induction protocol.
(D) Summary graph showing the average values
for the tw in the control and test paths, before and
after the induction protocol (control path: prein-
duction = 282 ± 23 ms, post-induction = 277 ±
22ms; test path: preinduction = 285 ± 22ms, post-
induction = 218 ± 16 ms).
(E) Summary graph for EPSC amplitude in the
presence of ifenprodil expressed as percentage of
pre-ifenprodil amplitude (control path, 41% ±
4.1%; test path, 76% ± 6.2%). n = 15 cells
throughout; slices prepared from P5–P7 rat;
*p < 0.05.
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Mechanisms for NR2B to NR2A Switcha signaling cascade involving PLC activation, release of calcium
from IP3R-dependent stores, and PKC activity is required.
However, unlike LTP-induced changes in AMPAR function, the
activity-dependent switch in NR2 subunit composition does
not require CaMKII or PKA activity. Using mGluR5 knockout
mice, we confirm the requirement for mGluR5 in acutely driving
the switch in CA1 hippocampus. Furthermore, we show that
the mGluR5 knockout mice have a deficient developmental
switch from NR2B- to NR2A-containing receptors at synapses
onto hippocampal CA1 pyramidal neurons and onto layer
2/3 pyramidal primary visual cortical neurons. Moreover, the
experience-dependent switch from NR2B to NR2A-containing
receptors in layer 2/3 visual cortex of dark-reared animals
induced by brief (2.5 hr) light exposure is absent in mGluR5
knockout mice. Thus, we define the mechanisms for the
activity-dependent switch in NR2 subunit composition at CA1
synapses and further demonstrate a crucial role in vivo for
mGluR5 in driving the experience-dependent switch in NR2
subunit composition.
RESULTS
Activity-Dependent Change in the NMDAR NR2 Subunit
Composition at Hippocampal CA1 Pyramidal
Cell Synapses
During the first week of postnatal development, most NMDARs
at cortical synapses contain NR2B, whereas by the third post-
natal week, a change in composition has occurred whereby
the majority of receptors now contain NR2A and lack NR2B
(Monyer et al., 1994; Sans et al., 2000; Sheng et al., 1994).340 Neuron 70, 339–351, April 28, 2011 ª2011 Elsevier Inc.Previous work shows that a pairing protocol, which induces
LTP of AMPAR-mediated synaptic transmission, also causes
a switch of NMDAR subunit composition from NR2B to NR2A
containing at CA1 synapses in acute hippocampal slices
prepared from postnatal day (P) 2–P9 rats (Bellone and Nicoll,
2007). We used this paradigm to investigate the mechanism for
the activity-dependent switch in NR2 subunit composition.
Using whole-cell patch-clamp recordings from CA1 pyramidal
neurons in acute hippocampal slices, we monitored pharmaco-
logically isolated NMDAR-mediated EPSCs (voltage clamped
at a holding potential of +40 mV to relieve voltage-dependent
magnesium block on the NMDAR, in the presence of 5 mM
NBQX and 50 mM picrotoxin) evoked at two independent
Schaffer collateral/commissural inputs. Following a baseline
period we applied a pairing protocol (1 Hz afferent stimulation
for 120 s at a holding potential of 0 mV) to one pathway (test
path). This induction protocol did not cause a change in NMDA
EPSC peak amplitude; however, it did produce a speeding of
NMDA EPSC decay in the test path, whereas the control path
did not exhibit any change in kinetics (Figures 1A and 1B). On
average, the weighted time constant (tw) for the EPSC decay in
the test path was 71 ms faster after the induction protocol
compared to before the induction protocol, whereas there
was no significant difference in the control path (Figure 1D).
In the same cells we then bath applied the NR2B selective
inhibitor, ifenprodil (5 mM), and found that the NMDA EPSCs in
the test path were blocked to a smaller degree than those
in the control path (Figures 1A and 1C). Across all cells, in
the control path, ifenprodil reduced the NMDAR EPSC ampli-
tude to 41% of pre-ifenprodil baseline (immediately prior to
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Mechanisms for NR2B to NR2A Switchifenprodil application), whereas in the test path, ifenprodil was
much less effective, only reducing EPSCs to 76% of predrug
amplitude (Figure 1E). These results confirm previous findings
(Bellone and Nicoll, 2007) that synaptic activity rapidly drives
a switch in synaptic NMDAR composition from those containing
NR2B to NR2A-containing receptors. Moreover, in these exper-
iments application of ifenprodil caused NMDA EPSC kinetics to
become faster in the control path; however, in the test path ifen-
prodil did not cause a speeding of kinetics (see Figure S1 avail-
able online). This lack of a significant change in kinetics in the test
path after application of ifenprodil reflects the small amount of
ifenprodil block at this input. These findings confirm that ifenpro-
dil exerts its action by selectively blocking NR2B-containing
NMDARs that mediate the slow kinetics of the EPSC and provide
further evidence that such receptors are removed from synapses
during LTP.
Previous work suggests that long periods of baseline stimula-
tion can itself induce plasticity of the NMDAR EPSC (Bellone and
Nicoll, 2007). Therefore, to determine if our baseline stimulation
protocol (ten EPSCs evoked at 0.1 Hz) was inducing any
plasticity, we reduced the baseline to four evoked responses
per path and then tested whether a similar degree of change in
kinetics and ifenprodil sensitivity could be induced by the induc-
tion protocol. Under these reduced baseline conditions, we
observed a similar degree of change in the NMDAR EPSC decay
kinetics and ifenprodil sensitivity produced by the induction
protocol compared with the previous data set with the longer
baseline (Figure S2). Thus, our baseline stimulation protocol itself
does not evoke significant activity-dependent changes in
NMDAR subunit composition.
The interpretation that NR2B-containing NMDARs are
removed from synapses and replaced with NR2A relies on the
changes in kinetics and pharmacology of the NMDAR EPSC.
However, for this latter assay, ifenprodil may have actions at
targets other than NR2B; therefore, in a separate set of experi-
ments, we tested changes in sensitivity to a secondNR2B-selec-
tive antagonist, Ro25-6981. We observed a very similar change
in the sensitivity to Ro25-6981 compared with ifenprodil
following induction of the NMDAR subunit switch (Figure S3).
In addition, we developed a culture model to directly image
changes in NR2B and NR2A synaptic localization. At DIV 4,
cultured hippocampal neurons were chronically treated with D-
AP5 to inhibit the developmental subunit switch. After 10 days,
D-AP5 was washed off, and the cultures were treated with
glycine to induce an acute switch in NR2 subunit composition.
This treatment caused an increase in surface NR2A localization
at synapses and a concomitant loss of NR2B (Figure S4). Taken
together, these findings provide strong evidence that activity
drives a rapid switch from NR2B- to NR2A-containing receptors
at synapses on CA1 pyramidal neurons.
The Activity-Dependent Change in NMDAR NR2 Subunit
Composition Requires mGluR5 and NMDARs
The activity-dependent switch in NR2 subunit composition is
rapid and input specific (Figure 1; Bellone and Nicoll, 2007).
However, the mechanism for its induction is unknown. To inves-
tigate this issue we first tested a role for glutamate receptors. As
shown in Figure 1, and as reported previously (Bellone and Nic-oll, 2007), the subunit switch can be induced in the presence of
NBQX, excluding a requirement for AMPAR activation in the
induction mechanism. We therefore hypothesized that NMDAR
and/or mGluR activation is required since both these mecha-
nisms cause a rise in spine-free calcium concentration that is
typically required for induction of synaptic plasticity. The
predominant postsynaptic mGluR subtype at CA1 pyramidal
cell synapses is mGluR5; therefore, we applied the induction
protocol in the presence of MTEP (10 mM), a selective mGluR5
antagonist (Cosford et al., 2003). MTEP fully blocked the
activity-dependent speeding of the NMDA EPSC decay kinetics
and reduction in NMDA EPSC ifenprodil sensitivity in the test
pathway (Figures 2A–2C, 2J, and 2K). We also tested whether
mGluR1 plays any role in the induction of the switch by testing
the effects of LY367385 (100 mM), a selective mGluR1 antagonist
(Kingston et al., 1999). However, LY367385 failed to block the
activity-induced switch in kinetics or ifenprodil sensitivity
(Figures 2D–2F, 2J, and 2K).
We next addressed a role for NMDARs themselves in the
induction of the NR2 subunit composition switch. NMDAR
activation requires depolarization to relieve the voltage-depen-
dent Mg2+ block to allow current flow through the ion channel.
Therefore, we first tested a requirement for postsynaptic depo-
larization in induction of the NR2 subunit switch. In cells in which
the test path was stimulated at 1 Hz while the cell was clamped
at 70 mV, the induction protocol failed to significantly change
the NMDA EPSC decay kinetics (Figure 2J) or ifenprodil sensi-
tivity (Figure 2K). In the next set of experiments to specifically
address the role of NMDARs, we blocked NMDA EPSCs with
D-AP5 (50 mM). Once the blockade was complete, we applied
the induction protocol and commenced washout of D-AP5
immediately. After 20 min of washout when NMDA EPSCs
had recovered to a stable amplitude, decay kinetics between
control and test pathways were compared and then ifenprodil
was bath applied (Figure 2G). D-AP5 completely prevented
the activity-dependent switch in NR2 subunit composition
(Figures 2H–2K). In control experiments we also tested whether
the inability to induce the NR2 subunit switch was due to the
extra 20 min delay between the induction protocol and the
recording of NMDAR EPSCs. We repeated the experiment in
the absence of D-AP5 and waited 20 min after the induction
protocol before comparing NMDAR EPSCs between the control
and test paths. Under these conditions, we still reliably
observed the differences in the NMDAR EPSC decay kinetics
and ifenprodil sensitivity between the control and test paths
(Figure S5).
Previous work has shown that another form of mGluR5-
dependent synaptic plasticity, mGluR LTD, requires new protein
translation for its expression (Huber et al., 2000). Therefore, we
tested whether the protein synthesis inhibitor cycloheximide
(60 mM), applied for 1 hr prior to and during the induction
protocol, blocked the switch. In the presence of cycloheximide,
the induction protocol caused robust changes in the NMDAR
EPSC decay kinetics and ifenprodil sensitivity (Figures 2J and
2K). Taken together, these findings show that the activity-depen-
dent switch in NMDAR NR2 subunit composition requires coac-
tivation of mGluR5 and NMDARs for its induction, but not
mGluR1 or new protein synthesis.Neuron 70, 339–351, April 28, 2011 ª2011 Elsevier Inc. 341
Figure 2. mGluR5 and NMDARActivation Are
Required for the Activity-Dependent Switch
in NR2 Subunit Composition
(A) Summary data of NMDA EPSC peak amplitude
versus time plot for two independent pathways onto
the same cell performed in the presence of bath-
applied MTEP (10 mM). In one pathway (test; red),
the induction protocol was applied; ifenprodil (5 mM)
was bath applied at the time indicated (n = 10).
(B) NMDA EPSCs from example experiments for the
test and control pathways taken from the experi-
ments in (A).
(C) NMDA EPSCs from an example experiment
showing changes in the ifenprodil sensitivity in the
control and test paths after application of the
induction protocol.
(D–F) The same as for (A)–(C), but in the presence of
LY367385 (100 mM; n = 7).
(G–I) The same as for (A)–(C), but in the presence of
D-AP5 (50 mM; n = 8).
(J) Summary graph showing the average values
for the tw in the control and test paths, before
and after the induction protocol in the presence of
the different antagonists (control path: MTEP =
289 ± 8.2 ms, LY367385 = 298 ± 10.5 ms, not
paired = 293 ± 14.3 ms, AP5 = 299 ± 11.2 ms,
cycloheximide = 302 ± 13.5 ms; test path: MTEP =
282 ± 9.1 ms, LY367385 = 225 ± 11.8 ms, not
paired = 276 ± 16.5 ms, AP5 = 302 ± 13.1 ms,
cycloheximide = 228 ± 11.5 ms).
(K) Summary graph for EPSC amplitude in the
presence of ifenprodil expressed as percentage
of pre-ifenprodil amplitude in the presence of
the different antagonists (control path: MTEP =
45.2% ± 5.1%, LY367385 = 42.1% ± 4.9%, not
paired = 41.1% ± 4.8%, AP5 = 44.4% ± 5.2%,
cycloheximide = 39.5% ± 4.8%; test path: MTEP =
52.3% ± 6.0%, LY367385 = 72.1% ± 7.5%, not
paired = 51.5% ± 5.3%, AP5 = 45.6% ± 4.5%,
cycloheximide = 64.5% ± 6.1%).
*p < 0.05. Summary data expressed as average ±
SEM.
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Mechanisms for NR2B to NR2A SwitchPLCandCalciumSignalingAreRequired for theActivity-
Dependent Switch in the NR2 Subunit Composition
Activation of either NMDARs or mGluR5 leads to a rise in intra-
cellular calcium. We first confirmed the requirement for a rise
in postsynaptic-free calcium concentration in the activity-depen-
dent NR2 subunit switch (Bellone and Nicoll, 2007) by using the
calcium chelator BAPTA (10 mM) in the whole-cell recording
solution. Postsynaptic BAPTA prevented the pairing protocol-342 Neuron 70, 339–351, April 28, 2011 ª2011 Elsevier Inc.induced speeding of NMDA EPSC kinetics
and reduction in ifenprodil sensitivity
(Figures 3J and 3K).
Whereas a role for calcium influx
through NMDARs in generating increases
in postsynaptic-free calcium concentra-
tion is well established, the role for
mGluR5-dependent calcium signaling at
spines is not so well characterized. To
investigate this issue we used two-photonlaser scanningmicroscopy and calcium imaging of spines in CA1
pyramidal neurons in neonatal hippocampal slices. Pyramidal
neurons were coloaded with a calcium-insensitive dye (Alexa
594) and the calcium-sensitive dye Fluo-5F via a patch elec-
trode. A stimulating electrode placed local to the dendrite of
interest was used to evoke minimal EPSCs, and a spine was
identified that responded with a calcium elevation (Figures S6A
and S6B). A paired-pulse stimulation protocol was employed
Figure 3. Signaling Requirements for the
Activity-Dependent Switch in NR2 Subunit
Composition
(A) Summary data of NMDA EPSC peak amplitude
versus time plot for two independent pathways onto
the same cell performed in the presence of bath-
applied U73122 (5 mM). In one pathway (test; red),
the induction protocol was applied, ifenprodil (5 mM)
was bath applied at the time indicated (n = 6).
(B) NMDAEPSCs from example experiments for the
test and control pathways taken from the experi-
ments in (A).
(C) NMDA EPSCs from an example experiment
showing changes in the ifenprodil sensitivity in the
control and test paths after application of the
induction protocol.
(D–F) As for (A)–(C), but in the presence of
GFX109203 (1 mM; n = 8).
(G–I) As for (A)–(C), but in the presence of H89
(10 mM; n = 6).
(J) Summary graph showing the average values for
the weighted time constant (tw) in the control and
test paths, before and after the induction protocol
in the presence of a number of different antagonists
(control path: BAPTA = 280 ± 12 ms, thapsigargin =
298 ± 14 ms, heparin = 278 ± 13 ms, 2APB = 302 ±
11 ms, U73122 = 293 ± 14 ms, GF109203X = 305 ±
10ms, KN93 = 298 ± 11ms, H89 = 311 ± 14ms; test
path: BAPTA = 271 ± 9 ms, thapsigargin = 276 ±
16 ms, heparin = 265 ± 14 ms, 2APB = 289 ± 13 ms,
U73122 = 286 ± 14 ms, GF109203X = 296 ± 13 ms,
KN93 = 228 ± 14 ms, H89 = 241 ± 12 ms).
(K) Summary graph for EPSC amplitude in the
presence of ifenprodil expressed as percentage of
pre-ifenprodil amplitude in the presence of the
different antagonists (control path: BAPTA =
39.8% ± 6.2 %, thapsigargin = 42.1% ± 7.9 %,
heparin = 38.6% ± 4.3 %, 2APB = 44.9% ± 6.7%,
U73122 = 43.9% ± 4.9 %, GF109203X = 43.2% ±
6.9%,KN93=39.6%±6.4%,H89=40.3%±5.5%;
test path: BAPTA = 40.1% ± 5.0 %, thapsigargin =
49.1% ± 5.7 %, heparin = 40.6% ± 5.6 %, 2APB =
41.6% ± 5.2 %, U73122 = 42.6% ± 3.8 %,
GF109203X = 39.5% ± 8.0 %, KN93 = 68.0% ±
7.2 %, H89 = 71.1% ± 6.5 %). Horizontal lines indi-
cate the average value in the control path in absence
of pharmacological agents; *p < 0.05. BAPTA,
10 mM, n = 6; thapsigargin, 5 mM, n = 7; heparin,
10 mg/ml, n = 6; 2APB, 100 mM, n = 7; GF109203X,
1 mM, n = 8; KN93, 10 mM, n = 7.
Neuron
Mechanisms for NR2B to NR2A Switchto more reliably elicit synaptic responses because failure rates
are high in response to single-shock stimulation when using
a minimal stimulation protocol. We then compared the spine
calcium transient evoked during baseline and in the presence
of MTEP and found that MTEP caused an 50% reduction in
the spine calcium response (Figures S6C–S6E). Thus, in these
neonatal CA1 pyramidal neurons, mGluR5 signaling mediatesNeuron 70, 339–a significant fraction of the evoked post-
synaptic calcium transient.
Glutamate binding to mGluR5 leads to
activation of PLC and release of calcium
from intracellular stores. To test a possiblerole for this downstream signaling pathway in driving the NR2
subunit switch, we first investigated whether U73122 (5 mM),
an inhibitor of PLC, blocked the induction of the subunit
switch. In the presence of bath-applied U73122, the induction
protocol failed to cause a speeding of NMDA EPSC decay
kinetics or reduction in ifenprodil sensitivity (Figures 3A–3C, 3J,
and 3K).351, April 28, 2011 ª2011 Elsevier Inc. 343
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Mechanisms for NR2B to NR2A SwitchWe next tested whether calcium release from intracellular
stores is involved in the subunit switch. In a first set of experi-
ments, we bath applied thapsigargin (5 mM), which blocks the
SERCA pump and causes a rapid depletion of intracellular
calcium stores in neurons. In the presence of thapsigargin, the
changes in EPSC kinetics and ifenprodil sensitivity were
completely blocked (Figures 3J and 3K). Since PLC activation
leads to synthesis of IP3, we tested a role for release of calcium
from IP3-sensitive stores using two IP3 receptor inhibitors,
heparin and 2APB. We included heparin (10 mg/ml) in the intra-
cellular solution, and in a separate set of experiments, we bath
applied 2APB (100 mM), which is membrane permeable. In
both sets of experiments, the induction protocol failed to cause
a change in NMDAEPSC kinetics or ifenprodil sensitivity (Figures
3J and 3K). PLC activity also leads to activation of PKCdue to the
synthesis of DAG and the rise in free calcium concentration that
potentially activates a number of PKC isoforms. Therefore, we
also tested whether PKC activity is required for the NR2 subunit
switch and found that application of the induction protocol in the
presence of bath-applied GF109203X (1 mM), a PKC inhibitor,
prevented the speeding of the NMDA EPSC kinetics and the
change in ifenprodil sensitivity (Figures 3D–3F, 3J, and 3K).
Finally, we also tested a role for PKA and CaMKII, two other
kinases known to be involved in synaptic plasticity at CA1
synapses (Malenka and Nicoll, 1999). However, neither inhibition
of PKA with H89 (10 mM) nor inhibition of CaMKII with KN93
(10 mM) prevented the activity-dependent change in decay
kinetics or ifenprodil sensitivity (Figures 3G–3K). Taken together,
these findings show that the activity-dependent switch in NR2
subunit composition requires PLC activity (but not CaMKII or
PKA activity), calcium release from postsynaptic IP3R-depen-
dent intracellular stores, and PKC activation.
The Activity-Dependent and Developmental Switch
in NR2 Subunit Composition at CA1 Synapses
Is Impaired in mGluR5 Knockout Mice
Our approach using multiple chemically unrelated inhibitors to
probe numerous steps in the same signaling pathway make it
very unlikely that the results we obtain can be explained by
off-target effects of the reagents. However, we also used
a genetic approach using mGluR5 knockout mice both to
confirm the role for mGluR5 in the activity-dependent NR2
subunit switch and also to study the role of mGluR5 in NMDAR
regulation in vivo. However, when we used the pairing protocol
compared with the rat slice experiments in hippocampal slices
from P5–P7 wild-type mice, we could not evoke any robust
change in NMDA EPSC kinetics or ifenprodil sensitivity (data
not shown). One possibility is that the ability to induce the
activity-dependent switch ‘‘washes out’’ rapidly in mouse CA1
pyramidal neurons during whole-cell recordings, similar to the
washout of AMPAR LTP commonly observed in CA1 pyramidal
neurons (Malinow and Tsien, 1990). Recent work shows that
high-frequency stimulation (100 Hz for 6 s) can change ifenprodil
sensitivity of NMDAR-mediated transmission at hippocampal
CA1 synapses in adolescent rats (Xu et al., 2009). Therefore,
we tested whether this induction protocol applied to the test
pathway prior to obtaining a whole-cell recording could induce
the NR2 subunit switch in slices from P5–P7 mice. Application344 Neuron 70, 339–351, April 28, 2011 ª2011 Elsevier Inc.of this high-frequency stimulation protocol to the test pathway
20–30 min prior to commencing whole-cell recording consis-
tently caused a speeding in the decay of NMDAR EPSCs in the
test path and a reduction in ifenprodil sensitivity compared to
the control path (Figures 4A–4C, 4J, and 4K). We next tested
whether the activity-dependent switch-induction mechanism in
mouse shares a similar signaling pathway with rat. The NR2B
to NR2A switch was blocked by MTEP, U73122, or AP5 (Figures
4D–4K), demonstrating that, like rat, the induction depends on
NMDARs, mGluR5, and PLC activation. Moreover, we also
tested the mouse induction protocol in rat hippocampal slices
and found that it also robustly evoked changes in NMDAR
EPSC kinetics and ifenprodil (Figure S7).
Next, we examined whether the activity-dependent NR2
subunit switch was deficient in mGluR5 knockout mice. We
compared slices from knockout and heterozygous littermates
with the experimenter blind to genotype. In hippocampal slices
from heterozygotes, the high-frequency induction protocol
caused a similar speeding of NMDA EPSC decay kinetics and
reduction in ifenprodil sensitivity, similar to that observed in
wild-types (Figures 5A–5C, 5G, and 5H). However, in slices
from the mGluR5 knockouts, although small variable changes
in NMDA EPSC decay and ifenprodil sensitivity occurred in
some experiments following the induction protocol, no signifi-
cant change in either of these parameters was observed (Figures
5D–5H).
If the activity-dependent switch underlies the developmental
regulation of NR2B/NR2A in vivo, a prediction is that the mGluR5
knockout mice should have altered regulation of NR2 subunit
composition in vivo during development. We investigated this
possibility by comparing kinetics and ifenprodil sensitivity of
NMDA EPSCs in mGluR5 knockout mice and wild-type litter-
mates. At P15–P18, NMDA EPSCs from CA1 pyramidal cells in
wild-type exhibited faster kinetics and a lower sensitivity to ifen-
prodil compared to knockouts (Figures 6A–6D). However, in the
knockouts there was still a considerable speeding in NMDA
EPSC kinetics and reduction in ifenprodil sensitivity during
development. Therefore, these findings show that there is
a deficit in the developmental switch from NR2B- to NR2A-con-
taining NMDARs in the mGluR5 knockout, demonstrating a role
for mGluR5 in this process. However, our data also show that
additional mechanisms can at least partly support the develop-
mental switch in the absence of mGluR5.
Deficient Experience-Dependent NR2B-NR2A Switch
in Visual Cortex of mGluR5 Knockout Mice
The developmental switch from NR2B to NR2A-containing
NMDARs isparticularlyprominent inprimarysensorycortexwhere
it has been shown to depend upon sensory experience. Particu-
larly well studied is this process in primary visual cortex of rodents
wherevisual experience for as little as1hrhasbeenshown todrive
the switch from NR2B to NR2A in dark-reared animals (Philpot
et al., 2001; Quinlan et al., 1999), and such regulation influences
metaplasticity and is required for maturation of receptive fields
(Cho et al., 2009; Philpot et al., 2003, 2007). To probe the role of
mGluR5 in the regulation of NMDAR function in vivo, we tested
whether the experience-dependent NR2B-NR2A switch is defi-
cient in primary visual cortex of mGluR5 knockout mice.
Figure 4. The Activity-Dependent Switch in
NR2 Subunit Composition Induced in
Mouse Hippocampal Slices
(A) Summary data of NMDA EPSC peak amplitude
versus time plot for two independent pathways
onto the same cell performed in mouse hippo-
campal slice (prepared from P5–P7 mouse). In
one pathway (test; red), the induction protocol
(100 Hz tetanus for 6 s) was applied prior to the
start of whole-cell recording; ifenprodil (5 mM) was
bath applied at the time indicated (n = 9).
(B) NMDA EPSCs from example experiments for
the test and control pathways taken from the
experiments in (A).
(C) NMDA EPSCs from an example experiment
showing changes in the ifenprodil sensitivity in the
control and test paths after application of the
induction protocol.
(D–F) The same as for (A)–(C), but in the presence
of MTEP (10 mM; n = 8).
(G–I) The same as for (A)–(C), but in the presence
of U73122 (5 mM; n = 7).
(J) Summary graph showing the average values
for the tw in the control and test paths, before and
after the induction protocol in control (CT) and in
the presence of the different antagonists (control
path: CT = 330 ± 20 ms, MTEP = 323 ± 17 ms,
U73122 = 318 ± 23 ms, APV = 305 ± 12 ms; test
path: CT = 229 ± 14 ms, MTEP = 312 ± 15 ms,
U73122 = 307 ± 18 ms, APV = 300 ± 15 ms).
(K) Summary graph for EPSC amplitude in the
presence of ifenprodil expressed as percentage of
pre-ifenprodil amplitude (control path: CT =
41.7% ± 4.1%, MTEP = 44.9% ± 5.8%, U73122 =
41.0% ± 3.5%, APV = 39.5% ± 6.9%; test path:
CT = 66.4% ± 3.3%, MTEP = 47.4% ± 4.6%,
U73122 = 43.4% ± 6.2%, APV = 44.6% ± 5.8%).
*p < 0.05. Summary data expressed as average ±
SEM.
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Mechanisms for NR2B to NR2A SwitchWefirstdeterminedwhether therewasadisruption in thedevel-
opmental switch from NR2B to NR2A in layer 2/3. We made
whole-cell patch-clamp recordings from layer 2/3 pyramidal
neurons in slices of primary visual cortex and found that NMDA
EPSCselicitedby layer4 stimulationexhibited longer decay times
and greater ifenprodil sensitivity in mGluR5 knockouts compared
to wild-type (Figures 6E–6H). This indicates a deficiency in the
development switch from NR2B to NR2A-containing receptors.
Visual experience in dark-reared rodents causes a rapid
switch from NR2B- to NR2A-containing NMDARs at layer 4Neuron 70, 339–3inputs onto layer 2/3 pyramidal neurons
in primary visual cortex that depends
upon NMDAR activation (Philpot et al.,
2001; Quinlan et al., 1999). Therefore,
we next tested whether this experience-
dependent plasticity is disrupted in
mGluR5 knockout mice. We dark
reared wild-type mice and mGluR5
knockout littermates from P6 until P17–
P19, exposed some of these animals to
2.5 hr of light, and then investigated theeffects on NMDA EPSCs at layer 4 inputs onto layer 2/3 pyra-
midal cells. In wild-type mice NMDA EPSCs in animals exposed
to light (+LE) exhibited faster kinetics and reduced ifenprodil
sensitivity compared to mice that did not receive light exposure
(Figures 7A–7E). The degree of change in these parameters was
very similar to that previously reported (Philpot et al., 2001;
Quinlan et al., 1999) and confirms that even brief exposure to
light can drive the switch from NR2B to NR2A in visual cortex.
In mGluR5 knockout mice light exposure failed to produce
any significant change in NMDA EPSC kinetics or ifenprodil51, April 28, 2011 ª2011 Elsevier Inc. 345
Figure 5. Impaired Activity-Dependent NR2
Subunit Switch in the mGluR5 Knockout
Mice
(A) Summary data of NMDA EPSC peak amplitude
versus time plot for two independent pathways
onto the same cell performed in hippocampal slice
from mGluR5 heterozygous (het) mouse (P5–P7).
In one pathway (test; red), the induction protocol
(100 Hz tetanus for 6 s) was applied prior to the
start of whole-cell recording; ifenprodil (5 mM) was
bath-applied at the time indicated (n = 16 mice).
(B) NMDA EPSCs from example experiments for
the test and control pathways taken from the
experiments in (A).
(C) NMDA EPSCs from an example experiment
showing changes in the ifenprodil sensitivity in the
control and test paths after application of the
induction protocol.
(D–F) The same as for (A)–(C), but for mGluR5
knockout (KO) (n = 9 mice).
(G) Summary graph showing the average values
for the tw in the control and test paths, before and
after the induction protocol in mGluR5 het mice
and mGluR5 KO (control path: het = 358 ± 8 ms,
KO = 361 ± 14 ms; test path: het = 284 ± 10 ms,
KO = 338 ± 29 ms).
(H) Summary graph for EPSC amplitude in the
presence of ifenprodil expressed as percentage of
pre-ifenprodil amplitude (control path: het =
41.0% ± 6.9%, KO = 37.9% ± 2.6%; test path:
het = 68.2% ± 3.7%, KO = 52.8% ± 6.5%).
*p < 0.05; **p < 0.01. Summary data expressed as
average ± SEM.
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Mechanisms for NR2B to NR2A Switchsensitivity (Figures 7A–7E). It was also noticeable that the dark-
reared wild-type and knockout mice (that were not exposed to
light) exhibited very similar NMDA EPSC kinetics and ifenprodil
sensitivity, indicating that visual experience and mGluR5 are
necessary for the developmental change from NR2B to NR2A-
containing NMDARs in visual cortex during the first few postnatal
weeks.
DISCUSSION
During the first postnatal week, most cortical synapses express
NR2B-containing receptors, whereas later in development
(>P14), many of these receptors are replacedwith NR2A-contain-
ingNMDARs. Synaptic activity is involved in regulating this switch,
and a role for sensory experience in primary sensory cortex has
also been demonstrated; however, the molecular mechanisms
driving this ubiquitous NMDAR subtype switch have hitherto
been largely unexplored. Here, we find that activation of both
mGluR5 and NMDARs is required for this switch to occur at
synapses on hippocampal CA1 pyramidal neurons. Furthermore,
we define a downstream signaling pathway involving PLC activa-346 Neuron 70, 339–351, April 28, 2011 ª2011 Elsevier Inc.tion, release of Ca2+ from IP3R-dependent
stores, and activation of PKC (see Figure 8
for model). Using mGluR5 knockout mice,
we confirm the requirement for mGluR5 in
the acute activity-dependent switch atCA1 synapses. Moreover, the mGluR5 knockouts show a deficit
in the developmental switch from NR2B to NR2A both at CA1
synapses and at inputs onto layer 2/3 pyramidal neurons in
primary visual cortex. Finally, we show that the NR2B-NR2A
switch driven by brief visual experience in layer 2/3 pyramidal
neurons in dark-reared mice is absent in the mGluR5 knockout.
These findings define the mechanism for the activity-dependent
NR2B-NR2A switch and suggest a central role for thismechanism
in the development- and experience-dependent regulation of
cortical NMDAR NR2 subunit composition.
Activity-Dependent Changes in NR2B and NR2A Subunit
Composition: Roles of mGluR5 and NMDARs
Our results show that an LTP induction protocol increases the
relative amount of NR2A at CA1 synapses in an mGluR5 and
NMDAR-dependent manner in the neonate. Moreover, mGluR5
function plays an important role in the rapid experience-driven
switch in NR2 subunit composition in pyramidal cells in layer
2/3 of the V1 cortex. In support of a requirement for mGluR5 and
NMDARs in the activity-dependent change in the NR2 subunits,
NMDARs are also required for this rapid experience-driven
Figure 6. Impaired Developmental Switch in NR2 Subunit Composi-
tion in Hippocampus and Primary Visual Cortex ofmGluR5 Knockout
Mice
(A) Scaled NMDA EPSCs from hippocampal example experiments taken from
wild-type (WT, black) and mGluR5 knockout (KO, red).
(B) NMDA EPSCs from hippocampal example experiments taken showing
ifenprodil sensitivity.
(C) Summary graph showing the average values for the tw in WT and mGluR5
KO at P15–P18 (WT, 195 ± 8 ms; KO, 238 ± 10 ms).
(D) Summary graph for EPSC amplitude in the presence of ifenprodil ex-
pressed as percentage of pre-ifenprodil amplitude for wild type (WT) and
mGluR5 knock-out (KO) at P15-18 (WT = 75.4% ± 4.0%, KO = 53.0%± 3.6%).
n = 8 mice.
(E–H) As for (A)–(D), but for layer 4 inputs onto layer 2/3 pyramidal neurons in
primary visual cortex from P15–P19 mice (decay kinetics: WT = 209 ± 9 ms,
KO = 249 ± 13 ms; ifenprodil sensitivity: WT = 67.4% ± 5.3 %, KO = 48.7% ±
3.4 %). n = 8 mice. *p < 0.05.
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Mechanisms for NR2B to NR2A SwitchNR2B-NR2A switch in primary visual cortex (Quinlan et al., 1999).
Together, these findings indicate that this mechanism may
represent a ubiquitous process in the developing brain for theactivity-dependent regulation of NMDAR function. This is in
addition to the variety of other mechanisms described for the
regulation of NMDAR function and trafficking in more mature
brain (for reviews see Chen and Roche, 2007; Lau and Zukin,
2007; Yashiro and Philpot, 2008). Whether the developmental
regulation of NR2 subunit composition also involves some of
the induction and expression mechanisms described in older
animals is unclear and will be of interest to study in future
work. High-frequency stimulation can also have long-lasting
potentiating effects on NMDAR-mediated synaptic transmission
in adult CA1 hippocampus (Bashir et al., 1991). Interestingly, this
NMDAR LTP is also dependent on mGluR5 and NMDAR activa-
tion (O’Connor et al., 1994; Jia et al., 1998; Kotecha et al., 2003;
Rebola et al., 2008). Recent work shows that such NMDAR LTP
also requires membrane fusion and causes a speeding in the
kinetics of the NMDA EPSC (Peng et al., 2010). However, in
the present study we did not observe significant changes in
NMDAR peak amplitudes after the induction protocol, suggest-
ing that in the neonate, NR2A-containing receptors replace
NR2B-containing receptors as opposed to being added to the
existing pool of synaptic NMDARs. Consistent with NMDAR
replacement in our experiments, NR2B-containing receptors
are more mobile and can diffuse to extrasynaptic sites at greater
rates than NR2A-containing receptors (Groc et al., 2006; Tovar
and Westbrook, 2002), and NMDARs more rapidly internalize
early in development (Washbourne et al., 2004; Roche et al.,
2001). Ifenprodil is not an effective inhibitor of NR1/NR2A dihe-
teromers or NR1/NR2A/NR2B triheteromers (Hatton and
Paoletti, 2005) at the concentrations we used. Therefore,
although we cannot be certain of the NMDAR subunit composi-
tion after the induction protocol, our data strongly suggest that
activity induces a loss of NR1/NR2B diheteromers and their
replacement with NR2A subunit-containing receptors. This
conclusion is further supported by the speeding of decay
kinetics, which indicates incorporation of NR2A subunit-contain-
ing receptors because this subunit produces receptors with
faster kinetics (Cull-Candy and Leszkiewicz, 2004).
Previous studies have shown that potentiation of NMDAR-
mediated transmission requires signaling downstream of
mGluR5, including release of Ca2+ from IP3R-sensitive stores,
and activation of PLC and PKC (Grosshans et al., 2002; Kotecha
et al., 2003; Kwon and Castillo, 2008; Jia et al., 1998). Although
the final mechanism driving the insertion of NR2A into synapses
is unclear, a recent study shows that the postsynaptic
membrane SNARE protein, SNAP-23, regulates NMDAR surface
expression at synapses in hippocampal CA1 pyramidal neurons
(Suh et al., 2010). We find that the activity-dependent switch in
NR2 subunit composition requires a rise in postsynaptic calcium
and release of calcium from IP3R-dependent stores. Moreover,
we find that at spines from neonates, mGluR5 contributes to
50% of calcium transients during synaptic transmission.
Thus, it is reasonable to speculate that the activity-dependent
switch in the NR2 subunit requires a certain threshold amount
of calcium provided by both NMDAR and mGluR5 activation.
Consistent with a role for IP3R-dependent store release,
previous work shows that at CA1 synapses, activity evokes
release of calcium from these stores (Ross et al., 2005). Further-
more, there is abundant evidence for the role of PLC and calciumNeuron 70, 339–351, April 28, 2011 ª2011 Elsevier Inc. 347
Figure 7. Impaired Sensory-Experience
Switch in the NR2 Subunit Composition in
mGluR5 Knockout Mice
(A) Scaled NMDA EPSCs from dark-reared wild-
type (WT, top) or mGluR5 knockout mice (KO,
bottom) without (black trace for WT and green
trace for KO) or with (red traces) 2.5 hr LE.
(B) Example traces for ifenprodil sensitivity in dark-
reared WT mice without LE (LE, top) or with LE
(+LE, bottom).
(C) Example traces for ifenprodil sensitivity in dark-
reared mGluR5 KO mice without LE (LE, top) or
with LE (+LE, bottom).
(D) Summary graph showing the average values
for the tw inWT andmGluR5 KOwith or without LE
(WT, 267 ± 18 ms; WT LE, 210 ± 9 ms; KO, 271 ±
10 ms; KO LE, 250 ± 8 ms).
(E) Summary graph for NMDAR EPSC amplitude in
the presence of ifenprodil expressed as
percentage of pre-ifenprodil amplitude for WT and
mGluR5 KO with or without LE (WT, 49.4% ±
3.8%; WT LE, 61.5% ± 3.7%; KO, 47.6% ± 3.9%;
KO LE, 53.5% ± 3.6%). n = 10 animals; *p < 0.05.
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Mechanisms for NR2B to NR2A Switchrelease from IP3R-dependent stores in various forms of synaptic
plasticity, e.g., Choi et al. (2005); Daw et al. (2002); Fernandez de
Sevilla et al. (2008); Gartner et al. (2006); Itoh et al. (2001); Taufiq
et al. (2005).
Although we have not formally tested whether all the hallmarks
of the subunit switching mechanism we describe in the slice also
occur in vivo, ours and other findings strongly suggest that this
mechanism is used in vivo to drive the switch from NR2B to
NR2A-containing NMDARs. We show that the developmental
switch in NR2 subunit composition is deficient in hippocampus
and visual cortex of mGluR5 knockout mice and that the sensory
experience-driven switching of NR2 subunit composition is
absent in mGluR5 knockouts. Moreover, previous work also
shows that in visual cortex, NMDARs are required for the experi-
ence-dependent switch in subunit composition (Quinlan et al.,
1999). Taken together, these findings strongly support the idea
that the mechanism we describe for the induction of the activity-
dependent switch as studied in hippocampal slices is used
in vivo to drive the NR2 subunit switch. However, the possibility
remains that additional mechanisms may also contribute in vivo,
and this may explain the partial switch from NR2B to NR2A that
is still observed during development in the mGluR5 knockouts.
Physiological Role
Long-term changes in synaptic efficacy are typically dependent
on calcium influx through NMDARs into postsynaptic spines.
The polarity of these synaptic changes (strengthening for LTP
and weakening for LTD) has been proposed to depend on the
amount and temporal dynamics of calcium influx, which could
be determined by the NR2 subunit composition of NMDARs
(Malenka and Bear, 2004; Yang et al., 1999). In addition to
calcium dynamics, differences in binding of signaling molecules
to the C-terminal tails of NR2A and NR2B (Strack and Colbran,348 Neuron 70, 339–351, April 28, 2011 ª2011 Elsevier Inc.1998; Barria and Malinow, 2005; Foster et al., 2010) may further
define the polarity of synaptic plasticity. Whether NR2B or NR2A
favors LTP or LTD, and vice versa, is still a matter ofmuch debate
(Bartlett et al., 2007; Liu et al., 2004; Morishita et al., 2007; Xu
et al., 2009). However, dysregulation of NR2 subtype expression
at synapses impairs hippocampus-dependent learning and
memory, demonstrating an important role for NR2 subunits in
plasticity (Sakimura et al., 1995; Sprengel et al., 1998; von Engel-
hardt et al., 2008). Sensory experience shapes cortical receptive
fields in primary sensory cortex during critical periods in an
NMDAR-dependent manner. In the visual cortex, a develop-
mental switch from NR2B- to NR2A-containing receptors coin-
cides with this critical period (Carmignoto and Vicini, 1992).
Also, visual experience or deprivation can rapidly increase or
decrease the NR2A/2B ratio of synaptic NMDARs in a reversible
manner (Philpot et al., 2001; Quinlan et al., 1999). Similarly,
whisker trimming during early postnatal development prevents
the developmental changes in the NR2 subunit in barrel cortex
(Mierau et al., 2004).
The experience-dependent switch from NR2B to NR2A has
important physiological consequences. In primary visual cortex,
where this has been most well characterized, the NR2B/NR2A
ratio regulates the degree of temporal summation of NMDAR-
mediated synaptic responses, sets the modification threshold
for synaptic plasticity, and regulates receptive field maturation
(Cho et al., 2009; Philpot et al., 2001, 2003). Moreover, a number
of neurological disorders involve dysregulation of NR2 subunits.
Increased NR2B surface expression is observed in Huntington’s
disease (Fan et al., 2007; Milnerwood et al., 2010), NMDAR
hypofunction, and altered NR2B/NR2A trafficking is found in
mouse models of schizophrenia (Mohn et al., 1999; Tang et al.,
2009). Abeta induces internalization of NMDARs in Alzheimer’s
disease models (Snyder et al., 2005), and there is increased
Figure 8. Mechanism for the Activity-Dependent Switch in NR2
Subunit Composition
Schematic of a dendritic spine showing the receptors and signaling pathways
involved in the activity-dependent NR2 subunit switch. The pharmacological
agents used to block the activity-dependent switch are also shown.
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Mechanisms for NR2B to NR2A Switchsurface expression of NR2A-containing NMDARs in cocaine
addiction (Borgland et al., 2006). Thus, understanding the
mechanisms of NR2B/NR2A regulation is important because
this can give insight intomechanisms underlying important phys-
iological and pathological changes in a number of brain areas
and for a number of different paradigms. Our findings now
provide the characterization of the novel induction mechanism
underlying a physiological regulation of NR2 subunit composi-
tion. Our data suggest that this mechanism is widely used in
cortical neurons, and it will be of great interest in future studies
to determine if this mechanism is also involved in pathological
changes in NMDAR subunit composition.
EXPERIMENTAL PROCEDURES
Electrophysiology
Four- to nine-day-old Wistar rats were anesthetized with isoflurane and then
decapitated in accordance with NIH animal care and use guidelines. Trans-
verse hippocampal slices (400 mm thick) were cut in ice-cold artificial cerebro-
spinal fluid (ACSF) containing: 119mMNaCl, 2.5mMKCl, 2.5mMCaCl2, 9mM
MgSO4, 1 mM NaH2PO4, 26.2 mM NaHCO3, 11 mM glucose equilibrated with
95% O2 and 5% CO2. Slices were then allowed to recover for at least 1 hr in
ACSF at room temperature (composition as above except for 1.3 mM
MgSO4). Whole-cell patch-clamp recordings were made from visually identi-
fied CA1 pyramidal neurons in the presence of 50 mM picrotoxin at room
temperature. The whole-cell solution contained 115 mM CsMeSO4, 20 mM
CsCl2, 10 mM HEPES, 2.5 mM MgCl2, 4 mM NaATP, 0.4 mM NaGTP,
10 mM NaCreatine, and 0.6 mM EGTA (pH 7.2). Preparation of hippocampal
and cortical slices from mice was similar except that the ice-cold ACSF for
cutting was of the following composition: 87 mM NaCl, 2.5 mM KCl, 0.5 mM
CaCl2, 25 mM NaHCO3, 1.25 mM NaH2PO4, 25 mM glucose, 75 mM sucrose
equilibrated with 95% O2 and 5% CO2. Slices were then placed at 35
C for
30 min and allowed to recover for at least 1 hr in ACSF at room temperature.
EPSCs were evoked by electrical stimulation of two independent popula-
tions of Schaffer collateral/commissural axons using two bipolar-stimulating
electrodes placed in stratum radiatum of CA1 (0.1 Hz stimulation frequency).
The stimulating electrodes were placed on opposite sides from recorded
cell from each other. For layer 2/3 pyramidal cell recordings from the visual
cortex, the stimulating electrode was placed in layer 4. NMDAR-mediatedEPSCs were obtained in the presence of NBQX (5 mM) and picrotoxin
(50 mM), while cells were voltage clamped at +40 mV. Recordings in which
the access resistance changed by more than 10% were discarded and not
included in our analysis. Recordings were performed using a MultiClamp
700B patch-clamp amplifier (Axon Instruments, Foster City, CA, USA); signals
were filtered at 4 kHz, digitized at 10 Hz, and displayed and analyzed online
using pClamp 9.2 (Axon Instruments). To drive the activity-dependent switch
in the subunit composition of synaptic NMDARs from rat slices, an LTP
induction protocol was employed, in which cells were voltage clamped at
0 mV, while Schaffer collateral/commissural axons were stimulated at 1 Hz
for 120 s, similar to that previously described (Bellone and Nicoll, 2007). Cells
were then voltage clamped at 70 mV for 5 min following LTP induction.
Following these 5 min, NMDAR EPSCs were once again recorded at a holding
potential of +40 mV. For mice, the induction protocol (100 Hz for 6 s) was
employed in the absence of NBQX, and 20–30 min prior to obtaining the
whole-cell configuration. For both rats and mice, the stimulating electrodes
for the test and control pathways were alternated to avoid differences in
NMDA EPSC due to proximal or distal synapses. Once cell per slice was
used, NMDA EPSC decay was fit with a double exponential function using
OriginLab software (Northampton, MA, USA), and decay kinetics are ex-
pressed as a weighted decay time constant. All receptor antagonists were
bath applied at least 20 min prior to and during the induction protocol. For
kinase inhibitors, slices were preincubated with inhibitors for at least 1 hr prior
to the induction protocol.
Dark Rearing
For dark rearing, male and female mice were used. Dark rearing commenced
at P6, and mice were raised in complete darkness until P17–P19. For light
experience (LE) experiments, dark-rearedmice were exposed to 2.5 hr of light.
Statistics
Values are mean ± standard error of the mean (SEM). Statistical significance
was tested using a Student’s t test. For all experiments in which genotype
was the experimental variable, the ‘‘n’’ was animal. All drugs, except for picro-
toxin (Sigma-Aldrich, St. Louis, MO, USA), were obtained from Tocris
Cookson.
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